SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Product Information [Line Items] | ||
| Accounts Receivable, Allowance for Credit Loss, Current | $ 0 | $ 0 |
| Asset Impairment Charges | 0 | 0 |
| Income Tax Examination, Penalties and Interest Accrued | $ 0 | $ 0 |
| Revenue Benchmark [Member] | One Customer [Member] | Customer Concentration Risk [Member] | ||
| Product Information [Line Items] | ||
| Concentration of credit risk, percentage | 79.00% | 100.00% |
| Revenue Benchmark [Member] | Another Customer [Member] | Customer Concentration Risk [Member] | ||
| Product Information [Line Items] | ||
| Concentration of credit risk, percentage | 20.00% | |
| X | ||||||||||
- Definition Amount of allowance for credit loss on accounts receivable, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|